
Continuous research, end-user feedback and close co-operation with specialty associations and key opinion leaders. All these allow Ansell Professional Healthcare to continuously develop new solutions incorporating innovative materials and coatings, resulting in even better protection and increased comfort levels for healthcare professionals. Ansell Professional Healthcare is committed to sustaining these efforts in the future and stepping up its addedvalue services, reinforcing its global market leadership position.

Ever since the natural rubber latex sensitivity problem was first recognised over fifteen years ago, Ansell Professional Healthcare has taken a proactive role in allergy management. Following research into reducing the onset of latex allergies, Ansell was the first company to adopt FITkit® tests, which detect the presence of key latex allergens. And Ansell
| | developed the P.E.A.R.L (Protein Endogenous Allergen Reduction Leaching) process, the most effective at decreasing allergen content in latex gloves, significantly reducing latex allergy risks. Low-allergen manufacturing methods, combined with the promotion of powder-free gloves, has reduced the prevalence of latex allergies substantially. This has allowed users to continue to benefit from the advantages of natural rubber latex. These include comfort, dexterity, and more environmentally-friendly, less-energy intensive fabrication and disposal processes than with synthetic gloves. For users suffering from Type I or Type IV latex allergies, Ansell Professional Healthcare provides a wide choice of synthetic gloves. | | 

In cooperation with the Université Catholique de Louvain in Belgium, Ansell Professional Healthcare built a unique dynamic testing device to measure the permeation rate of medical gloves for the most widely used types of cytostatics. Data sourced from this scientific research provide more accurate and safer guidelines for gloves used when handling chemotherapy drugs. Ansell Professional Healthcare’s ongoing commitment to this issue has yielded solutions that provide extra protection for healthcare workers handling cytostatic agents. |